Developing new antimicrobials from animal microbial partners
Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
['FUNDING_OTHER'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-10592380
This study is looking for new medicines to fight infections by exploring the helpful relationships between animals and the tiny germs that live with them, aiming to find better treatments for tough germs that don't respond to regular antibiotics.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WISCONSIN-MADISON (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-10592380 on ClinicalTrials.gov |
What this research studies
This research aims to discover new antimicrobial drugs by exploring natural products derived from the symbiotic relationships between animals and their microbial partners. The project utilizes innovative and interdisciplinary approaches to overcome challenges in traditional antimicrobial discovery. By focusing on under-explored biological and chemical diversity, the researchers hope to identify effective therapies against drug-resistant pathogens that pose a significant threat to public health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by multi-drug resistant pathogens.
Not a fit: Patients with infections that are not caused by drug-resistant pathogens may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel antimicrobial therapies that effectively combat drug-resistant infections.
How similar studies have performed: Other research has shown promise in discovering new antimicrobials from natural sources, indicating that this approach could yield significant results.
Where this research is happening
MADISON, UNITED STATES
- UNIVERSITY OF WISCONSIN-MADISON — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ANDES, DAVID R — UNIVERSITY OF WISCONSIN-MADISON
- Study coordinator: ANDES, DAVID R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: communicable disease control agent